Ad26.RSV.FA2

BIOLOGICAL2 trials

Sponsors

Crucell Holland BV

Conditions

Healthy ParticipantsRespiratory Syncytial VirusesRespiratory Tract Infections

Phase 1

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad35.RSV.FA2 Regimens Boosted With Ad26.RSV.FA2 in Healthy Adult Participants

CompletedNCT02440035

Crucell Holland BVHealthy Participants

Start: 2015-04-21End: 2016-06-09Updated: 2017-08-22

A Study to Evaluate the Safety, Tolerability and Immunogenicity of Ad26.RSV.FA2 Followed by Ad35.RSV.FA2 in Healthy Adult Volunteers

CompletedNCT02561871

Crucell Holland BVRespiratory Syncytial Viruses, Respiratory Tract Infections

Start: 2015-09-30End: 2016-09-30Updated: 2016-11-01